A Novel Multi-Targeting Approach to Treating Hair Loss, Using Standardized Nutraceuticals

November 2017 | Volume 16 | Issue 11 | Supplement Individual Articles | 141 | Copyright © November 2017


Patricia K. Farris MD,a Nicole Rogers MD,a Amy McMichael MD,b Sophia Kogan MDc

aTulane University, Metaire, LA bWake Forest School of Medicine, Winston-Salem, NC cNutraceutical Wellness Inc, New York, NY

REFERENCES

  1. Anunciato TP, da Rocha Filho PA. Carotenoids and polyphenols in nutricosmetics, nutraceuticals, and cosmeceuticals. J Cosmet Dermatol. 2012;11(1):51-54.
  2. Guo EL, Katta R. Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatol Pract Concept. 2017;7(1):1-10.
  3. Brown AC. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food Chem Toxicol. 2016.
  4. Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184-189.
  5. Hunt N, McHale S. The psychological impact of alopecia. BMJ. 2005;331(7522):951-953.
  6. Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol. 1993;29(4):568-575.
  7. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004;123(3):455-457.
  8. Rogers NE AM. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008;59(4):20.
  9. Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011;65(6):1126-1134 e1122.
  10. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186-194.
  11. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141-1150.
  12. Dawber RP, Rundegren J. Hypertrichosis in females applying minoxidil topical solution and in normal controls. J Eur Acad Dermatol Venereol. 2003;17(3):271-275.
  13. Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002;46(2):309-312.
  14. Prahalada S, Tarantal AF, Harris GS, et al. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology. 1997;55(2):119-131.
  15. Kiguradze T, Temps WH, Yarnold PR, et al. Persistent erectile dysfunction in men exposed to the 5alpha-reductase inhibitors, finasteride, or dutasteride. PeerJ. 2017;5:e3020.
  16. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med. 2011;8(3):872-884.
  17. Gur S KP, Hellstron WJ. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire, and ejaculation. Expert Opin Drug Saf 2014;12(1):10.
  18. Beitkopf T LG, Yu M, et al. The basic science of hair biology. What are the causal mechanisms for the disordered hair follicle? Derm Clinic. 2013;31:1-19.
  19. Magro CM, Rossi A, Poe J, Manhas-Bhutani S, Sadick N. The role of inflammation and immunity in the pathogenesis of androgenetic alopecia. J Drugs Dermatol. 2011;10(12):1404-1411.
  20. Upton JH, Hannen RF, Bahta AW, Farjo N, Farjo B, Philpott MP. Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia. J Invest Dermatol. 2015;135(5):1244-1252.
  21. Ramos PM, Brianezi G, Martins AC, da Silva MG, Marques ME, Miot HA. Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation. Int J Cosmet Sci. 2016;38(6):651-654.
  22. Trueb RM. The impact of oxidative stress on hair. Int J Cosmet Sci. 2015;37 Suppl 2:25-30.
  23. Choudhry SZ, Bhatia N, Ceilley R, et al. Role of oral Polypodium leucotomos extract in dermatologic diseases: a review of the literature. J Drugs Dermatol. 2014;13(2):148-153.
  24. Ni Z, Mu Y, Gulati O. Treatment of melasma with Pycnogenol. Phytother Res. 2002;16(6):567-571.
  25. Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. J Eur Acad Dermatol Venereol. 2007;21(7):942-950.
  26. Goel A KA, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787-809.
  27. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195-218.
  28. Fadus MC LC, Bikhchandi, Lynch H. Curcumin; An age-old anti-inflammatory and anti-neoplastic agent. J Trad Comp Med. 2016.
  29. Liu Z, Dou W, Zheng Y, et al. Curcumin upregulates Nrf2 nuclear translocation and protects rat hepatic stellate cells against oxidative stress. Mol Med Rep. 2016;13(2):1717-1724.
  30. Nakamura K, Yasunaga Y, Segawa T, et al. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol. 2002;21(4):825-830.
  31. Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors. 2013;39(1):37-55.Jang S, Lee Y, Hwang SL, et al. Establishment of type II 5alpha-reductase over-expressing cell line as an inhibitor screening model. J Steroid Biochem Mol Biol. 2007;107(3-5):245-252.
  32. Suphrom N, Pumthong G, Khorana N, Waranuch N, Limpeanchob N, Ingkaninan K. Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb. Fitoterapia. 2012;83(5):864-871.
  33. Pumthong G, Asawanonda P, Varothai S, et al. Curcuma aeruginosa, a novel botanically derived 5alpha-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012;23(5):385-392.
  34. Huh S, Lee J, Jung E, et al. A cell-based system for screening hair growth-promoting agents. Arch Dermatol Res. 2009;301(5):381-385.
  35. Arck PC, Slominski A, Theoharides TC, Peters EMJ, Paus R. Neuroimmunology of Stress: Skin Takes Center Stage. J Invest Dermatol. 2006;126(8):1697-1704.
  36. Thom E. Stress and the Hair Growth Cycle: Cortisol-Induced Hair Growth Disruption. J Drugs Dermatol. 2016;15(8):1001-1004.
  37. Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. Br J Pharmacology. 2013;170(1):23-37.
  38. Nishikawa H, Tsutsumi J, Kitani S. Anti-inflammatory and anti-oxidative effect of curcumin in connective tissue type mast cell. Journal of Functional Foods. 2013;5(2):763-772.
  39. Arora V, Kuhad A, Tiwari V, Chopra K. Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences. Psychoneuroendocrinology. 2011;36(10):1570-1581.
  40. Panahi Y, Sahebkar A, Amiri M, et al. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutrition. 2011;108(7):1272-1279.
  41. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807-818.
  42. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. 1999;27(4):486-494.
  43. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353-356.
  44. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin. Indian J Pharm Sci. 2008;70(4):445-449.
  45. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012;26(11):1719-1725.
  46. Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav. 2003;75(3):547-555.
  47. Singh G SP, Dudhe R, Singh S. Biological activities of Withania somnifera. Ann Biol Res. 2010:56-63.
  48. Auddy B HJ, Mitra A, Abedon B, Ghosal S. A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study. J Am Nutraceut Assoc. 2008;11(1):50-66.
  49. Snehal S. Patel JKS. Systematic review of plant steroids as potential anti- inflammatory agents: Current status and future perspectives. The Journal of Phytopharmacology. 2015;4(2):121-125.
  50. Bhattacharya SK GR, Kaur R, Ghosal S. Anti - stress activity of Sitoindosides VII and VIII. New Acylsterylglucosides from Withania somnifera. Phytother Res 1987;1:32-37.
  51. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera, the Indian Ginseng. Cell Mol Life Sci. 2015;72(23):4445-4460.
  52. Ruchi Tiwari SC SM, Dhara K et al. Ashwagandha (Withania somnifera): role in safeguarding health, immunomodulatory effect, combating infections and therapuetic applications: A review. Jour Biol Sci 2014;14(2):77-94.
  53. Pingali Usharani NF. Evaluation of a highly standardized Withania somnifera extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double blind, placebo controlled study. Int J Ayur Pharma Res. 2014;2(3):22-32.
  54. Suter A, Saller R, Riedi E, Heinrich M. Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial. Phytother Res. 2013;27(2):218-226.
  55. Ooi SL, Pak SC. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and its Clinical Implications in Naturopathic Medicine. J Altern Complement Med. 2017.
  56. Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002;8(2):143-152.
  57. Rossi A EM, et al. . Comparative effectiveness of finasteride and serenoa repens in male androgenetic alopecia: a two year study. . International Journal of Immunopathology and Pharmacology. 2012;25(4).
  58. Yang S, Chen C, Li Y, et al. Saw palmetto extract enhances erectile responses by inhibition of phosphodiesterase 5 activity and increase in inducible nitric oxide synthase messenger ribonucleic acid expression in rat and rabbit corpus cavernosum. Urology. 2013;81(6):1380 e1387-1313.
  59. Habib FK, Ross M, K.H. Ho C, Lyons V, Chapman K. Serenoa repens (Permixon®) inhibits the 5α-reductase activity of human prostate cancer cell lines without interfering with PSA expression. International Journal of Cancer. 2005;114(2):190-194.
  60. AM. P. Vitamin E. Tocopherols and Tocotrienols. Antioxidant status, diet, nutrition, and health. CRC Press.198-210.
  61. Serbinova E, Kagan V, Han D, Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med. 1991;10(5):263-275.
  62. Ahsan H, Ahad A, Iqbal J, Siddiqui WA. Pharmacological potential of tocotrienols: a review. Nutr Metab (Lond). 2014;11(1):52.
  63. Naziroglu M, Kokcam I. Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct. 2000;18(3):169-173.
  64. Beoy LA, Woei WJ, Hay YK. Effects of tocotrienol supplementation on hair growth in human volunteers. Trop Life Sci Res. 2010;21(2):91-99.
  65. Wang Y, Park NY, Jang Y, Ma A, Jiang Q. Vitamin E gamma-Tocotrienol Inhibits Cytokine-Stimulated NF-kappaB Activation by Induction of Anti-Inflammatory A20 via Stress Adaptive Response Due to Modulation of Sphingolipids. J Immunol. 2015;195(1):126-133.
  66. Kesarwani K, Gupta R, Mukerjee A. Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed. 2013;3(4):253-266.
  67. McNamara FN RA, Gunthorpe MJ. Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol. 2005;144(6):781-790.
  68. (ed.) PSL. The Gastrointestinal System: Gastrointestinal, Nutritional, and Hepatobiliary Physiology. Springer Science + Business Media Dordrecht. 2014:35-62.
  69. Atal N, Bedi KL. Bioenhancers: Revolutionary concept to market. J Ayurveda Integr Med. 2010;1(2):96-99.
  70. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(Pt 24):4195-4200.
  71. Watanabe-Kamiyama M, Shimizu M, Kamiyama S, et al. Absorption and effectiveness of orally administered low molecular weight collagen hydrolysate in rats. J Agric Food Chem. 2010;58(2):835-841.
  72. Matsuda N, Koyama Y, Hosaka Y, et al. Effects of ingestion of collagen peptide on collagen fibrils and glycosaminoglycans in the dermis. J Nutr Sci Vitaminol (Tokyo). 2006;52(3):211-215.
  73. Zhuang Y HH, Zhao X et al. Effect of collagen and collagen hydrolysates from jellyfish (Rhopilema esculentum) on mice skin photoaging induced by UV irradiation. J Food Sci. 2009;74:H183-H188.
  74. Tana M KY-I, Nomura Y. . Effect of collagen peptide ingestion of UVB-induced skin damage. Biosci Biotechnol Biochem. 2009;73:930-932.
  75. G A. A double-blind, placebo-controlled study evaluating the efficacy of an oral supplement in women with self-perceived thinning hair. J Clin Aesthet Dermatol. 2012;5:28-34.
  76. Lassus A EE. Treatment of hereditary androgenetic alopecia in young males. International Med Res. 1992;20:445-453.

AUTHOR CORRESPONDENCE

Sophia Kogan MD sophia@nutrafol.com
Close Menu